Latest Advances

  • Condition: Diabetic Macular Edema
  • Journal: Journal of diabetes research
  • Treatment Used: Bevacizumab
  • Number of Patients: 89
  • Published —
The study researched the use of bevacizumab for treating diabetic macular edema.
  • Condition: Cystoid Macular Edema Secondary to Paclitaxel Therapy for Pancreatic Cancer
  • Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • Treatment Used: Paclitaxel Discontinuation
  • Number of Patients: 1
  • Published —
This case report describes a 71-year-old man diagnosed with cystoid macular edema (swelling) secondary to paclitaxel therapy for pancreatic cancer treated with paclitaxel discontinuation.
  • Condition: Vitreoretinal Disease
  • Journal: PloS one
  • Treatment Used: 23-Gauge vs. 25-Gauge Vitrectomy Surgery
  • Number of Patients: 195
  • Published —
The aim of this study was to assess and compare safety and effectiveness between 23-gauge and 25-gauge vitrectomy systems for the treatment of common vitreoretinal diseases in non-vitrectomized eyes.
  • Condition: Chronic Diabetic Macular Edema
  • Journal: Scientific reports
  • Treatment Used: Fluocinolone Acetonide (FAc) Vitreous Insert
  • Number of Patients: 0
  • Published —
This review of the literature examined fluocinolone acetonide (FAc) intravitreal implant for patients with chronic diabetic macular edema (DMO).
  • Condition: Non-infectious Intraocular Inflammation after Intravitreal Anti-Vascular Endothelial Growth Factor Injection
  • Journal: Turkish journal of ophthalmology
  • Treatment Used: Topical Steroid Therapy
  • Number of Patients: 1966
  • Published —
The study researched the use of non-infectious intraocular inflammation after intravitreal anti-vascular endothelial growth factor injection for the treatment of neovascular age-related macular degeneration (nAMD).
  • Condition: Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration
  • Journal: Turkish journal of ophthalmology
  • Treatment Used: Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement
  • Number of Patients: 30
  • Published —
The aim of the study was to understand the functional and morphological outcomes of vitrectomy in combination with intravitreal 5% C3F8 tamponade and subretinal injections of tissue plasminogen activator (tPA) and anti-vascular endothelial growth factor (anti-VEGF) in patients with submacular hemorrhage (SMH).
  • Condition: Diabetic Macular Edema
  • Journal: Journal of diabetes research
  • Treatment Used: One Versus Three Monthly Aflibercept Injections
  • Number of Patients: 71
  • Published —
In this study, researchers compared the effectiveness of one versus three monthly aflibercept injections for the treatment of diabetic macular edema.
  • Condition: Complicated Cataract
  • Journal: Vestnik oftalmologii
  • Treatment Used: Hybrid Phacoemulsification
  • Number of Patients: 78
  • Published —
In this study, researchers evaluated the outcomes of using hybrid phacoemulsification for the treatment of hypermature cataract in patients with lens subluxation.
  • Condition: Polypoidal Choroidal Vasculopathy
  • Journal: BMC ophthalmology
  • Treatment Used: Aflibercept
  • Number of Patients: 25
  • Published —
The study researched the use of Aflibercept for treating polypoidal choroidal vasculopathy.
  • Condition: Neovascular Age-Related Macular Degeneration
  • Journal: BMC ophthalmology
  • Treatment Used: Intravitreal Aflibercept
  • Number of Patients: 342
  • Published —
The study researched the outcomes of intravitreal aflibercept for ranibizumab-refractory patients with neovascular age-related macular degeneration.
Showing 1-12 of 380